Visitor Registration is Now Open: www.analyticavietnam2025.events-regis.com/Two exhibition halls featuring the latest in laboratory technology, analysis, and biotech solutions.Over 300 exhibitors and brands from across the globe, offering cutting-edge products and innovations.New features like the Start-Up Pavilion, Live Lab Demo, Innovation Zone, and Lab Design & Construction Forum.HO CHI MINH CITY, VIETNAM, Mar 6, 2025 - (ACN Newswire via SeaPRwire.com) - analytica Vietnam 2025, the country’s largest and most influential trade fair for laboratory technology, analysis, and biotechnology, is set to return bigger than ever. Taking place from 2-4 April 2025 at the Saigon Exhibition and Convention Center (SECC), Ho Chi Minh City, this 8th edition will be the largest in the event’s history, expanding to two exhibition halls and welcoming over 300 exhibitors and brands, and 6,000 trade visitors from across the region.Endorsed by the Ministry of Science and Technology in Vietnam and supported by the National Agency for Science and Technology Information (NASATI), Center for Science and Technology Information (CESTI), Key Laboratory of Analytical Technology for Environmental Quality and Food Safety Control (KLATEFOS), VNU, Federal Ministry for Economic Affairs and Climate Action of Germany, and the Association of Small & Medium Enterprises (Singapore), analytica Vietnam 2025 continues to uphold its reputation as a leading industry event.Global Participation and Networking OpportunitiesThis year’s edition will see extensive global participation, with dedicated pavilions from Germany, Singapore, and China, alongside exhibitors from Vietnam, Malaysia, Japan, South Korea, the UK, Switzerland, France, Spain, Turkey, India, and the USA. The event continues to serve as a premier platform for networking, innovation, and business development in the industry. Michael Wilton, Managing Director of MMI Asia, the organizer of analytica Vietnam, expressed, "The continuous growth of analytica Vietnam reflects the increasing demand for advanced laboratory and analytical solutions across Vietnam and the region. Expanding to two halls not only accommodates more exhibitors but also opens up new avenues for collaboration, knowledge exchange, and innovation. We’re excited to welcome professionals from all over the world to experience our largest and most comprehensive edition yet."What to Expect at analytica Vietnam 2025?Academic Conference: Learn from internationally renowned experts as they share research, trends, and findings on topics such as Environmental and Green Chemistry, Food and Quality Control, Pharmaceutical Analysis & Health Science, and Future Technologies.Live Lab Demo: This interactive feature brings advanced analytical instruments, automation, and testing procedures to life, allowing visitors to witness real-time applications across various industries.Innovation Zone: A dedicated area showcasing the newest and most groundbreaking products in laboratory technology, analysis, and biotech solutions.Lab 4.0 Exhibitor Forum: Explore a range of innovative technologies and solutions transforming laboratory operations. Topics will include automation, digitalization, advanced data analytics, new materials, and cutting-edge techniques in laboratory management and research.Lab Design and Construction Forum: Gain insights into the latest trends in lab design, energy-efficient solutions, sustainable practices, and innovative layouts. Industry experts and renowned speakers will share their expertise on creating modern laboratories that meet both functionality and environmental standards.Lucky Draw: Stand a chance to win exciting prizes sponsored by our esteemed exhibitors.Hosted Buyer Program: The largest program yet, with key buyers from Vietnam, Cambodia, Thailand, and Malaysia, invited for exclusive business meetings with exhibitors.Vincent Au Yeong, Country Manager of ITS Vietnam, the event’s Bronze Sponsor, shared, "As a customer of analytica Vietnam for nearly 10 years, I have witnessed the event’s growth and the valuable benefits it brings each year. The continuous development of analytica has reinforced our confidence in its ability to provide insights, foster partnerships, and stay ahead of industry trends. We’re proud to be part of this long-term journey and look forward to further growth together. We can’t wait to meet both our longtime and new customers here."Top 15 Products You Can Look Forward to Seeing at the Exhibition:1. Mixer Mill MM 400 by ITS2. PacBio Revio/Onso Sequencing System by DKSH3. Xevo MRT Mass Spectrometer by Waters4. Liquid Chromatograph Mass Spectrometer by Shimadzu5. epMotion 5075 by Eppendorf6. Biosafety cabinet, Tangerine by Oriental Giken7. High-Speed Amino Acid Analyzer LA8080 by 2H Instrument8. EMC Magnetic Cell Holder by EMCLAB Instruments GmbH9. Hot Head by ELDEX CORPORATION10. Gas generator for TOC Gas Analysis by cmc Instruments GmbH11. Sykam Amino Acid Analyzers by Hoa Viet Co., Ltd12. SCIEX ZenoTOF 7600 SCIEX ZenoTOF 7600 LC-MS/MS System Model: ZenoTOF 7600 by Viet Nguyen Co.,ltd13. Avio 550 ICP-OES - Perkin Elmer14. MIRI® Time-Lapse Incubat or by ESCO15. AI - RIDA®SMART APP Allergen (2024) by R-BiopharmBe Part of analytica Vietnam 2025 – Register Today!To make the most of your experience at analytica Vietnam 2025, we recommend that trade visitors register in advance. This will ensure seamless access to the event and provide updates on the latest developments. For more information and to complete your registration, please visit www.analyticavietnam2025.events-regis.com/About analytica Vietnamanalytica Vietnam is the premier trade fair for laboratory technology, analysis, and biotechnology in Southeast Asia. Organized by Messe München, the event brings together industry professionals, researchers, and policymakers to showcase the latest technologies, exchange knowledge, and foster business collaborations. analytica Vietnam features an exhibition, conference, pre-event laboratory tours, buyer-seller programs, and networking opportunities, providing a comprehensive platform for the laboratory and biotechnology industries in the region. The upcoming edition is set to take place from April 2 to 4, 2025 at the SECC – Saigon Exhibition and Convention Center. More details can be found at https://www.analyticavietnam.com/.About analytica worldwideMesse München is the world’s leading trade fair organizer for laboratory technology, analysis and biotechnology. The international network of exhibitions includes analytica, analytica China, analytica Anacon India & India Lab Expo, analytica Vietnam, analytica USA, and analytica Lab Africa. Additional information about these exhibitions and their programs of events is available at.About MMI Asia Pte LtdEstablished in 1992, MMI Asia is the wholly owned subsidiary and the regional headquarters of Messe München GMBH (MMG) and is one of the world largest and leading exhibition organizers. MMI Asia’s portfolio of events include editions of worldleading trade fairs from Munich – transport logistic & air cargo, analytica, ceramitec; as well as industry-specific events such as Glasstech and Fenestration Asia, Asia Climate Forum, and Singapore International Water Week. MMI Asia also provides consultancy in professional trade fair and conference management to government bodies, international trade and promotion organizations, and trade associations. For more information, please visit www.mmiasia.comAbout Messe MünchenAs one of the world’s leading trade fair organizers, Messe München presents the world of tomorrow at its about 90 trade fairs worldwide. These include twelve of the world’s leading trade fairs such as bauma, BAU, IFAT, electronica, and ISPO. Messe München’s portfolio comprises trade fairs for capital and consumer goods, as well as for new technologies. Together with its subsidiaries, it organizes trade fairs in China, India, Brazil, South Africa, Turkey, Singapore, Vietnam, Hong Kong, Thailand, and the U.S. With a network of more than 15 affiliated companies and almost 70 representations worldwide, Messe München is active in more than 130 countries. The more than 150 events held annually attract around 50,000 exhibitors and around three million visitors in Germany and abroad.Exhibition Contact:MMI Asia Pte. Ltd.Daniel ShiExhibition Directordaniel@mmiasia.com.sgPress Contact:MMI Asia Pte. Ltd.Joey NgMarketing Executivejoey@mmiasia.com.sg Copyright 2025 ACN Newswire via SeaPRwire.com.

SHANGHAI, Mar 3, 2025 - (ACN Newswire via SeaPRwire.com) - On February 27th, the awarding ceremony of the second batch of Shanghai Innovative Enterprise Headquarters was held in Shanghai. Gong Zheng, Deputy Secretary of Shanghai Municipal Party Committee and Mayor of Shanghai, awarded the certificates to 49 innovative enterprise headquarters, and Hua Medicine was among them. Dr. Li Chen, the founder and CEO of the Company, went on stage to receive the award and delivered a speech as a representative of the enterprises.(Gong Zheng, Deputy Secretary of Shanghai Municipal Party Committee andMayor of Shanghai, awarded the titles to innovative enterprise headquarters)Innovative enterprises are an important part of Shanghai's modern industrial system and the source of vitality for Shanghai's high-quality development. In recent years, innovative enterprises in Shanghai have been growing and developing rapidly, having an obvious driving effect on the industry. The enterprises awarded this time are from key industrial fields such as integrated circuits, biomedicine, artificial intelligence, digital economy, and emerging strategic comprehensive industries. All the selected enterprises exhibit the characteristics of strong innovation leadership, vigorous development vitality, and obvious agglomeration development. (Certificate of innovative enterprise headquarters)Hua Medicine, headquartered in Shanghai but with a global outlook, is leveraging China's evolving pharmaceutical regulatory landscape and the innovative drug full-chain industrial environment such as the pharmaceutical research and development, production, and business environment created by Shanghai to continuously accelerate the transformation and implementation of innovative achievements. Hua Medicine took ten years to develop a globally first-in-class and national Class I new drug, glucokinase activator (GKA) dorzagliatin (Trade name:) independently, which was first launched in China, with a globally new target and a new mechanism.In September 2022, dorzagliatin was approved for marketing by the National Medical Products Administration of China for the treatment of type 2 diabetes. It is the first GKA approved for marketing worldwide and has also become the tenth class of diabetes treatment drugs recognized by the World Health Organization (WHO). By the end of 2023, dorzagliatin was successfully included in China's National Reimbursement Drug List (NRDL), greatly improving the accessibility and affordability of this innovative drug for patients.As a global innovation leader in the GKA field, Hua Medicine has received national-level awards on multiple occasions during the research and development period and after the product launch, and has undertaken major national projects. These include being consecutively selected as a major new drug development special project under the "12th Five-Year Plan" and the "13th Five-Year Plan” by the Ministry of Science and Technology, and winning the First Prize of the Science and Technology Award of the Chinese Pharmaceutical Association, among others. Currently, Hua Medicine is actively carrying out the development of the second-generation GKA and fixed combination preparations, aiming to bring more innovative and good drugs to patients in China and even globally in the fields of diabetes and its complications, such as obesity and diabetic nephropathy. (Dr. Li Chen delivered a speech as a representative of the enterprises)As a representative of the enterprises, Dr. Li Chen said in his speech at the awarding ceremony: "Coinciding with the new era and new journey of Shanghai accelerating the construction of a scientific and technological innovation center and fully promoting the upgrading and development of strategic emerging industries, Hua Medicine being recognized as the Shanghai Innovative Enterprise Headquarters is an affirmation of the enterprise's past and also an encouragement and inspiration for the enterprise's future development. Hua Medicine will continue to leverage its advantages of conceptual innovation, technological innovation, and model innovation, keep making progress, and contribute to the construction of Shanghai's scientific and technological innovation center and the innovative development of the biomedicine industry."Receiving the title of "Shanghai Innovative Enterprise Headquarters" this time is not only an honor for Hua Medicine but also a responsibility and mission. In the future, taking this as an opportunity, Hua Medicine will continuously increase its innovation investment and the ability of achievement transformation, continuously enhance its international competitiveness, provide more high-quality innovative drugs and treatment solutions for patients, help Shanghai's biomedicine industry reach new heights, and promote the construction of the "Healthy China" strategy.About Hua MedicineHua Medicine (The “Company”) is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin for adult T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with renal function impairment.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaEmail: pr@huamedicine.com Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Mar 3, 2025 - (ACN Newswire via SeaPRwire.com) - Nissin Foods (Hong Kong) Charity Fund (“Charity Fund”) announced its continued support for outstanding food and nutritional sciences students from The Chinese University of Hong Kong (“CUHK”) for the third consecutive year. The 2024-2025 Nissin Foods Scholarship Presentation Ceremony was held today to present scholarships to 13 undergraduate and postgraduate students, who strive for excellence in their academic performance and aspire to become future industry leaders.Established by the Charity Fund and CUHK in 2022, the scholarship will cover their full tuition fees for the academic year, and is renewable, subject to annual performance review, with the intent to support the students throughout their study period, so that they can focus on their studies without worrying about financial burdens. The four new awardees for the 2024-2025 academic year are: LEUNG Hau Man, LO Chun Hei and WONG Siu Yu from CUHK’s Bachelor of Science in Food and Nutritional Sciences programme, and ZHOU Zhengming from the PhD programme. The nine renewed awardees are LAM Tsz Hang, SHUM Wai Hang, CHAN Hoi Yi, HSU Po Ling, KWAN Ka Yi, LAM Shuk Fan and WONG Wai Yee from the Bachelor’s degree programme, and ZHOU Dandan, LIN Yuhong from the PhD programme. Mr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund, said, "At Nissin Foods, we believe that food-related jobs are sacred professions. They serve both life and society. We share the values with The Chinese University of Hong Kong in nurturing outstanding and caring food professionals, who will contribute to Hong Kong's development. By empowering students studying food and nutritional sciences in CUHK and elite athletes aspiring to become teachers from the Education University of Hong Kong, we promote a healthy lifestyle through food and sports. This reflects the vision of our founder, Mr. Momofuku Ando, who said, ‘Eating and sports are the two axles of health."Professor Anthony CHAN, Pro-Vice-Chancellor and Vice-President of The Chinese University of Hong Kong, expressed his genuine gratitude for the generous support of the Charity Fund to CUHK, said, "Mr. Momofuku Ando, the Founder of Nissin Foods, was a visionary leader who dedicated himself to serve our society through technological innovation and had the courage to create positive change in our lives. His spirit continues to inspire many of us. CUHK has all along been committed to providing fertile ground for nurturing the future leaders of our society. We feel privileged that our vision in advancing higher education has been shared by Nissin Foods."Ms. WONG Wai Yee, on behalf of all the scholarship recipients, thanked the Charity Fund and CUHK for setting up the scholarship scheme and presented a booklet of appreciation from the 13 awardees to Mr. Kiyotaka ANDO. She said, "This scholarship empowers us to pursue our passions and aspirations in the realm of food and nutrition without constraints. As Nissin Foods Scholars, we are driven by a spirit of innovation to contribute to solutions for a secure and healthy global food supply, ensuring that the benefits of food and nutrition reach every corner of the world."PhotoMr. Kiyotaka ANDO, Chairman of Nissin Foods (Hong Kong) Charity Fund (middle right), and Professor Anthony CHAN, Pro-Vice-Chancellor and Vice-President of CUHK (middle left), attended the 2024-2025 Nissin Foods Scholarship Presentation Ceremony today. There are 13 scholarship recipients for the 2024-2025 academic year. The four new awardees this year are (front, from left to right) LEUNG Hau Man, LO Chun Hei and WONG Siu Yu from CUHK’s Bachelor of Science in Food and Nutritional Sciences programme, and ZHOU Zhengming from the PhD programme. The nine renewed awardees are: (back, from left to right) LAM Tsz Hang, SHUM Wai Hang, ZHOU Dandan, CHAN Hoi Yi, HSU Po Ling, KWAN Ka Yi, LAM Shuk Fan and WONG Wai Yee, and LIN Yuhong from the Bachelor’s degree or the PhD programme.About Nissin Foods (Hong Kong) Charity FundThe Nissin Foods (Hong Kong) Charity Fund (“Charity Fund”) was set up in September 2020 by way of a trust deed by Nissin Foods Company Limited (Stock code: 1475). The objectives of the Charity Fund are: a) to advance education, teaching, learning, arts, science and academic research; b) to make provision for people in need; and c) to carry out works of a charitable nature that are beneficial to the Hong Kong community. Copyright 2025 ACN Newswire via SeaPRwire.com.

SOLANA BEACH, CA, Mar 4, 2025 - (ACN Newswire via SeaPRwire.com) - American Wave Machines, the global leader in world-class surf pool destinations, has begun commissioning PerfectSwell® in the heart of Brazil's vibrant financial center São Paulo. AWM has partnered with JHSF, Brazil's leading high-end real estate development company, on their second PerfectSwell® location, the São Paulo Surf Club. With the iconic Ponte Estaiada bridge as a backdrop, top Brazilian Pros Italo Ferreira and Miguel Pupo, along with AWM's Rob Kelly, put the latest PerfectSwell® innovations through the paces. Commissioning will be completed in March."Our team has done an incredible job. Improvements in PerfectSwell® efficiency, performance, and maintainability are ongoing along with continuing wave design innovations. A lot of R & D went into maintaining ride length and guest beach space in a totally unique footprint," said Bruce McFarland, CEO and Founder of AWM. "The effort has paid off and PerfectSwell® is working great. It's an unsurpassed surf experience."Rob Kelly takes to the air at the newest PerfectSwell® pool in São Paulo. Photo Courtesy of Bruno Zanin.WSL Surfer Miguel Pupo said "It's a mind-blowing experience to surf in the heart of the city in another incredible JHSF venue design. There's so much power in these waves. We surfed the McFly, an incredible air section, and the other new waves, they're all addicting. I can't get myself to get out of the water.""This is the fifth PerfectSwell® commissioning I've been a part of and it's easily the most iconic destination created yet. There are several improvements that have exceeded expectations including our newest wave energy dampening system," said Miquel Lazaro Cordero, lead engineer at AWM. "These improvements have made it possible for us to bring our highest performance surf in this dense urban environment."São Paulo Surf Club with the city's iconic Ponte Estaiada bridge as backdrop. Photo Courtesy of JHSF.About American Wave MachinesAmerican Wave Machines, Inc. is the inventor and developer of PerfectSwell® Surf Technology. AWM's technology powers world class surf facilities and destinations backed by proven financials, extensive data capture, and stoked surfers. PerfectSwell® is the only sequence based, pneumatic surf technology on the market. Protected by over 50 patents worldwide, PerfectSwell® Split Peaks, Peeling Waves, Air Sections, and Wedge Barrels are all covered by AWM's robust patent portfolio.About JHSFJHSF is a Brazil-based holding company and leader in the high-income real estate industry in Brazil, engaged in real estate development, shopping mall and fashion retail and hospitality and gastronomy. Founded in 1972, the company's main area of operation and investment is in the high-income segment, with a focus on recurring income activities. The company, which has been publicly traded since 2007 and has its shares listed on B3's Novo Mercado, operates in both the Brazilian market and other countries, such as the United States and Uruguay. It was the first company in the Brazilian real estate sector to prioritize recurring income assets, including the operation of shopping centers, an airport, and hotels, in addition to real estate projects. For more information visit jhsf.com.brContact:Jenna Timinskyinfo@americanwavemachines.comSOURCE: American Wave Machines, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.